Updated 07:15 GMT, 18 Nov 2026 SPX 7,340.53 -1.03% NDX 27,001.78 -0.72% VIX 25.46 +11.13% GOLD 3,772.20 -2.38% CL 83.98 -2.36% BTC 64,721.99 -0.26%
NAS100 27,002 −0.72% S&P 7,341 −1.03% GOLD $3,772 −2.38% BTC $64,722 −0.26% VIX 25.46 +11.13% latest tape · as of 07:15 UTC
The Screen · Consumer Cyclical · Textile Manufacturing

Albany International Corp. logoAlbany International Corp.

AIN · the NYSE · USD · Market cap $1.9B · 5,700 employees

Albany International Corp., together with its subsidiaries, engages in the machine clothing and engineered composites businesses in the United States, Switzerland, France, Brazil, China, Mexico, Germany, and internationally.

PASS · Titan Ethical · score 70.0
65.72 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 07:15 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price65.72 USD at the 17 Nov 2026 close
  • Our value readFair vs our fair value, as of 17 Nov 2026
  • Our regime readMarkup, as of 16 Nov 2026
  • Ethical screenPasses, score 70.0 out of 100
  • OptionsOpen interest leans to puts (put/call 1.33)
  • Last reviewed17 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $63.90 to $86.93, base estimate $70.27 (screen dated 2026-11-17).

Current read
Markup ?
Fair · screened 2026-11-17
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options put/call open interest 1.33, read 2026-11-17
  • Ethical passes the values gate
Price65.72 USD
Fair value70.27
Ethical score70.0/100
Value readFairas of 17 Nov 2026
Our investment reviews on this name
2026-10-24Read Markup65.00+1.1% to today ✓Accumulation gives way to Markup after a 7% rise in 6 days
2026-10-18Read Accumulation60.70+8.3% to today ✓Markdown gives way to Accumulation with volume flow in agreement
2026-10-11Read Markdown59.31+10.8% to today Markup gives way to Markdown while volume still accumulates
2026-09-21Read Markup60.20+9.2% to today ✓Distribution gives way to Markup after a 6% slide in 4 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

Albany International Corp. holds its Markup at $65.72. Consolidating, no directional conviction, held for 9 days.

As held on the ledger · 2026-11-17
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 9 days
Price at the screen$65.72
Valuation21.62 trailing · 20.79 forward price to earnings
Values screenPASS · score 70.0
Beta1.16
The Workings

Five Screens, Shown in Full

Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.

TestFigureLimitWhat it meansStatus
Business activity Permissible Core business clean Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. Pass
Debt load 27.19% Below 33% Interest-bearing debt is just 27.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. Pass
Interest-bearing cash 0.00% Below 33% Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. Pass
Receivables 19.43% Below 49% Money owed to the company is 19.4% of assets, under the 49% limit. Pass
Revenue purity 0.44% Below 5% Only 0.4% of revenue comes from non-compliant sources, under the 5% line. Pass

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Clears, in Plain English

Albany International clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 27%, inside the ~33% line, and almost none of its income is interest, so it passes.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when AIN's ethical verdict changes

Today AIN passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Fair vs our fair value, as of 17 Nov 2026: it trades at roughly a 6% discount to our $70.27 fair value, 33.70% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

63.90Conservative70.27Base case86.93Growth case 65.72Price

Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. A 6.5% discount to the base estimate.

The Street's Range
71.00Street low 71.00Street average 75.00Street high 65.72Price

Third-party analyst targets: 3 covering, consensus Hold. The average target sits +8% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $70.27, with a range of $63.90 to $86.93, dated to the 2026-11-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Machine clothing firm priced far above fair value

Picture the endless belts that turn raw pulp into paper or reinforce aircraft parts. Albany International makes those critical components, yet the numbers show a business still posting losses and negative returns on equity while revenue edges up just 8 percent.

We pass because the shares sit 45 percent above our fair value with a forward multiple of 24 times and no economic moat visible. Analyst targets cluster around 61 dollars and the consensus is merely hold, so the market already sees limited upside.

Cyclical exposure in textiles and composites adds the usual earnings swings, and any recovery could easily disappoint if volumes stall. Analysis, not advice.

The fundamentals · plain-English read
Forward P/E20.8xcheap for a company growing this fast
Trailing P/E21.6xa premium valuation
EPS, trailing3.04
EPS, forward3.16
Revenue growth+33.7%strong top-line growth
Profit margin6.7%thin but positive margins
Return on equity11.6%a modest return on shareholder capital
FCF yield3.89%
Dividend yield1.73%
Debt to equity0.54moderate, manageable leverage
Current ratio2.41comfortably covers its short-term bills
Beta1.16moves a little more than the market
Short interest, float0.04%
52-week range41.15 - 77.00
Market cap$1.9B
Employees5,700

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

AIN trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-18 Markup $65.72 -4.6% Entry 21

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 4.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57.

2026-11-11 Markup $68.92 -6.4% Entry 20

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 6.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57.

2026-11-04 Markup $73.67 +13.3% Entry 19

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 13.3% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57.

2026-10-28 Markup $65.00 +0.0% Entry 18

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-27 Markup $65.00 +0.0% Entry 17

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-26 Markup $65.00 +0.0% Entry 16

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bullish. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-25 Markup $65.00 +0.0% Entry 15

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-24 Markup · changed $65.00 +0.0% Entry 14

The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-23 Accumulation $65.00 +0.0% Entry 13

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.

2026-10-22 Accumulation $65.00 +7.1% Entry 12

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are up 0%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (3 analysts) rates it hold, with a mean price target of $57. It reported earnings in this window, a natural checkpoint for the thesis.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

Latest News · What the Market Is Reading on AIN

Headlines from third-party outlets, linked for reference: not our reporting, not advice.

Related Securities · Others in AIN's Space

Screened names in the same industry · explore each on its own page.

The Political Ledger · Congressional Disclosures
Disclosures naming AIN
DatePoliticianPartyTypeAmount
2026-10-06 Gil Cisneros Democrat sell 1K–15K
2026-08-25 April McClain Delaney Democrat sell 100K–250K
2026-08-25 April McClain Delaney Democrat sell 100K–250K
2026-08-25 April McClain Delaney Democrat sell 100K–250K
2026-08-25 April McClain Delaney Democrat sell 100K–250K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $61.17 +10.2% $0.28 $1,107 +10.7%
2 months $56.97 +18.3% $0.28 $1,188 +18.8%
3 months $54.14 +24.5% $0.56 $1,255 +25.5%
6 months $52.29 +28.9% $0.84 $1,305 +30.5%
1 year $67.23 +0.3% $1.11 $1,019 +1.9%
2 years $80.87 -16.7% $2.18 $860 -14.0%
3 years $86.90 -22.4% $3.21 $813 -18.7%
5 years $83.18 -19.0% $5.00 $871 -12.9%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever AIN does next, these words stay.

Albany International Corp. · AIN · Markup · $65.72
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.